fbpx

Latest news

IDWeek: Optimal Vancomycin Dosing using Bayesian Method Poster Presentations
2 Oct 2019 | Media Release

IDWeek: Optimal Vancomycin Dosing using Bayesian Method Poster Presentations

We're excited to share DoseMe will present two poster presentations at IDWeek 2019 in Washington, DC from October 2-6th. Predictive Ability and Bias of Vancomycin Population PK models in an Obese Adult Population Friday, 12:15-1:30pm EDT, Poster #1574 The aim of this study is to evaluate the performance...

Read more
BayCare Health System to Present on Improved Pharmacy Operations using DoseMeRx at CHC2019
24 Sep 2019 | Media Release

BayCare Health System to Present on Improved Pharmacy Operations using DoseMeRx at CHC2019

Moorestown, NJ, September 23, 2019 - Tabula Rasa HealthCare, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announced its subsidiary DoseMe and BayCare Health System will present at the Cerner Health Conference (CHC)...

Read more
DoseMe Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study
20 Sep 2019 | Media Release

DoseMe Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study

Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced an independent study evaluating Bayesian Forecasting (BF) programs found TRHC’s DoseMe BF program - DoseMeRx - to be the most user-friendly. BF programs, such as DoseMeRx, use patient data and laboratory...

Read more
BayCare Health System To Showcase DoseMeRx at CHC 2019

BayCare Health System To Showcase DoseMeRx at CHC 2019

In just under one month, DoseMe is exhibiting at the Cerner Health Conference (CHC) from October 7th - 9th in Kansas City, Missouri. The Cerner Health Conference (CHC) 2019 is your hub for the latest innovations in health care and information technology. Each year, thousands of clients rely on...

Read more
DoseMeRx Rated Most User-Friendly in Clinical Study -Read the study →

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.